Department of Basic Health Sciences, Universidad de Caldas, Manizales, Colombia.
Physiol Meas. 2020 Jul 7;41(6):064005. doi: 10.1088/1361-6579/ab8e5f.
All definitions for diagnosing sarcopenia include the estimation of muscle mass. This can be made using bioelectrical impedance analysis (BIA) or dual x-ray absorptiometry (DXA). BIA is a portable and inexpensive method suitable for clinical settings, while DXA is cumbersome, more expensive and less available.
To evaluate the interchangeability of both techniques for skeletal muscle mass index (SMI) estimation, and assess whether the two methods are comparable for the diagnosis of sarcopenia.
Prospective, cross-sectional study.
Faculty for Health Sciences, Universidad de Caldas, Colombia.
Seventy-two subjects aged 65-80 years were recruited.
BIA and DXA for SMI estimation and sarcopenia diagnoses using the definition of the European Working Group on Sarcopenia in Older People (EWGSOP). Of the 72 patients, 28 were diagnosed with sarcopenia by BIA and corroborated by DXA were included in the study. To establish the agreement between techniques, the intraclass correlation coefficient and the concordance correlation coefficient were calculated. A Bland-Altman plot evaluated the agreement. To evaluate agreement on the diagnosis of sarcopenia, a Cohen's kappa test was performed.
Agreement between SMI by BIA and DXA was good according to the intraclass correlation coefficient (ICC 0.7 95% CI 0.5 to 0.8) but poor when the concordance correlation coefficient was used (CCC 0.4 was calculated 95% CI 0.3 to 0.5). The Bland-Altman analysis showed a clinically unacceptable discrepancy between the methods; the confidence intervals were too wide; the difference between methods tends to get larger as the average increases and the scatter around the bias line get larger as the average gets higher. Cohen's kappa test was 0.2 (SEE: 0.1).
The agreement between BIA and DXA was weak. We concluded that, in this studied population, the methods were not interchangeable. Results may improve if a specific formula in a greater sample size is used.
所有诊断肌少症的定义都包括肌肉量的估计。这可以通过生物电阻抗分析(BIA)或双能 X 线吸收法(DXA)来实现。BIA 是一种适合临床环境的便携式且廉价的方法,而 DXA 则繁琐、昂贵且可用性较低。
评估这两种技术在估计骨骼肌指数(SMI)方面的可互换性,并评估这两种方法在诊断肌少症方面是否具有可比性。
前瞻性、横断面研究。
哥伦比亚卡尔达斯大学健康科学学院。
招募了 72 名年龄在 65-80 岁的受试者。
使用欧洲老年人肌少症工作组(EWGSOP)的定义,通过 BIA 和 DXA 来估计 SMI 和诊断肌少症。在 72 名患者中,有 28 名患者通过 BIA 诊断为肌少症,并通过 DXA 证实,这些患者被纳入本研究。为了确定两种技术之间的一致性,计算了组内相关系数和一致性相关系数。Bland-Altman 图评估了一致性。为了评估在肌少症诊断方面的一致性,进行了 Cohen's kappa 检验。
根据组内相关系数(ICC 0.7,95%CI 0.5 至 0.8),BIA 和 DXA 测量的 SMI 之间的一致性良好,但使用一致性相关系数时则较差(计算出的 CCC 为 0.4,95%CI 为 0.3 至 0.5)。Bland-Altman 分析显示两种方法之间存在临床不可接受的差异;置信区间太宽;随着平均值的增加,方法之间的差异趋于增大,而随着平均值的升高,围绕偏差线的离散度也增大。Cohen's kappa 检验为 0.2(SEE:0.1)。
BIA 和 DXA 之间的一致性较弱。我们得出结论,在该研究人群中,这两种方法不可互换。如果在更大的样本量中使用特定公式,结果可能会有所改善。